JPRN-UMIN000011177已完成未知
The efficacy and safety of combination therapy of adoptive immunotherapy with chemotherapy for advanced pancreatic cancer - Combination therapy of immunotherapy with chemotherapy for pancreatic cancer
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Interstitial pneumonia 2. Active autoimmune disease 3. Uncontroled infection 4. Severe drug allergy 5. Continued steroid therapy 6. Pregnancy 7. HIV or HTLV-1 positive
研究者
相似试验
进行中（未招募）
不适用
COMET TrialJPRN-jRCTs031180210Yokote Koutaro60
已完成
不适用
Effectiveness and safety of Combination therapy of Ranibizumab and LuseOgliflozin in type 2 diabetes with diabetic Macular Edema, a parallel group comparison with the standard Treatment controlled by Glimepiride, multicenter, randomized, open-label trial. (COMET Trial)JPRN-UMIN000033961Chiba University60
进行中（未招募）
1 期
Safety and efficacy of combination treatment with rituximab and leflunomide in patients with active rheumatoid arthritis - Rituximab and Leflunomide in RAEUCTR2005-004582-41-GBniversity of Leeds15
已完成
2 期
Efficacy and tolerability of combination therapy with aprepitant,palonosetron,and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based chemotherapy for gynecological cancer(Phase II Study)gynecological cancerJPRN-UMIN000003820Kansai Clinical Oncology Group -Gynecologic Cancer Group-100
已完成
不适用
A study on the efficacy of combination therapy of insulin and ipragliflozin in patients with type 2 diabetesJPRN-UMIN000014798Imamura clinic15